MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, SONN had $171,841 increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$171,841
Unit: Dollar
Positive Cash Flow Breakdown
    • Proceeds from issuance of common...
    • Accounts payable
    • Prepaid expenses and other curre...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Payment of financing costs relat...
    • Operating lease liability
    • Others

Cash Flow
2025-06-30
Share-based compensation
60,395
Non-cash financing costs
3,044
Amortization of operating lease right-of-use asset
58,777
Net loss
-10,427,632
Prepaid expenses and other current assets
-805,527
Operating lease liability
-62,027
Other assets
-7,766
Accrued expenses and other current liabilities
66,118
Deferred income
0
Accounts payable
1,540,535
Depreciation
7,669
Incentive tax receivable
-164,685
Financing costs related to chef purchase agreement
520,200
Acquired in-process research and development
114,399
Net cash used in operating activities
-7,140,544
Purchases of in-process research and development
12,000
Net cash used in investing activities
-12,000
Proceeds from issuance of common stock, net of issuance costs
7,803,453
Payment of financing costs related to chef purchase agreement
465,200
Proceeds from exercise and modification of warrants, net of issuance costs
-13,868
Payment of deferred offering costs
0
Net cash provided by financing activities
7,324,385
Net increase in cash
171,841
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock, net of...$7,803,453 Net cash provided byfinancing activities$7,324,385 Canceled cashflow$479,068 Net increase in cash$171,841 Canceled cashflow$7,152,544 Payment of financingcosts related to chef...$465,200 Proceeds from exerciseand modification of...-$13,868 Accounts payable$1,540,535 Prepaid expenses andother current assets-$805,527 Financing costs related tochef purchase...$520,200 Incentive tax receivable-$164,685 Acquired in-processresearch and development$114,399 Accrued expenses andother current...$66,118 Share-based compensation$60,395 Amortization of operatinglease right-of-use...$58,777 Other assets-$7,766 Depreciation$7,669 Non-cash financing costs$3,044 Net cash used inoperating activities-$7,140,544 Net cash used ininvesting activities-$12,000 Canceled cashflow$3,349,115 Net loss-$10,427,632 Purchases of in-processresearch and development$12,000 Operating lease liability-$62,027

Sonnet BioTherapeutics Holdings, Inc. (SONN)

Sonnet BioTherapeutics Holdings, Inc. (SONN)